Suicide Prevention Week is September 4-10. Are you ready?
In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.
Cannabis use disorder and nonadherence: How can we best educate patients?
Frontal lobe syndrome can present with a range of perseverative, disinhibited, overactive behaviors that do not meet traditional dementia/neurocognitive disorder criteria. Learn more here.
Many individuals with dementia wander. How can caregivers keep their loved ones with dementia safe?
It is time for gender-sensitive first-episode psychosis services.
Brain Capital: a fresh approach to technologies and investing.
Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP provide some advice to clinicians on explaining schizophrenia to patients and caregivers to achieve understanding and therapy adherence.
Digital therapeutics may be the biggest paradigm-shifting change medicine has seen yet...
EmPATH units revolutionize emergency psychiatry, offering rapid, compassionate care for behavioral health crises and improving community outcomes.
The climate crisis is increasingly challenging human well-being. What can the psychiatric field do to help?
In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.
Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?
ECT has been in use for decades, but does that mean it is safe or effective?
Rikinkumar Patel, MD, MPH, shares some recent research findings with Psychiatric Times at the 2024 Annual Meeting.
How can this new model help us link brain-based innovation with economics?
How can we ensure an accountable, effective, and limited conservatorship system? Here are some actionable concepts.
During the first day on the job, a psychiatry resident sees patients who need help, but there are problems with the system designed to help them.
Research on a new kind of cannabis treatment prepares to move forward.
Innovation award presented to early career psychiatrist promotes exploration and research in the use of neurostimulation for psychiatric disorders.
With art we build what poverty destroys.
COVID-19 has prompted an unprecedented shift toward virtual psychiatric health care—but how do patients and providers really feel about it?
It is an uncomfortable emotion that is often suppressed—but potent.
In this custom video series, Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, shares advice that can be helpful to community providers who manage children and adult patients prescribed antipsychotic therapy about screening for involuntary body movements and early signs of tardive dyskinesia.
In this CME article, learn more about the efficacy and tolerability of brexpiprazole for the treatment of agitation among individuals with Alzheimer disease dementia.
Brain Capital: a fresh approach to technologies and investing.
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.